查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612245

生物醫學人工智慧市場：按組件、技術、應用和最終用戶分類 - 2025-2030 年全球預測

Artificial Intelligence in Biomedical Market by Components (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Application, End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年生物醫學領域人工智慧市場規模為47億美元，預計2024年將達57.8億美元，複合年成長率為24.18%，預計2030年將達214億美元。

人工智慧（AI）在生物醫學領域的應用範圍廣泛，從藥物發現、基因組學、醫學影像處理到病患監測和個人化醫療。人工智慧具有快速分析大型資料集、識別複雜模式和預測結果的能力，對於改善決策流程和業務效率至關重要。作為應用，機器學習、自然語言處理和機器人流程自動化等人工智慧技術被用來最佳化臨床試驗、提高診斷準確性並加快藥物開發過程。最終用途領域包括醫療保健提供者、製藥公司、研究機構等。市場成長的主要驅動力是精準醫療需求的不斷成長、人工智慧技術的進步以及不斷成長的醫療資料。此外，政府支持人工智慧和物聯網（IoT）整合的舉措正在加強人工智慧在生物醫學應用中的應用。

主要市場統計
基準年[2023] 47億美元
預計年份 [2024] 57.8億美元
預測年份 [2030] 214億美元
複合年成長率（%） 24.18%

影響成長的關鍵因素包括醫療保健支出的增加、有利的法規環境以及科技公司與醫療保健提供者之間的合作。然而，市場擴張面臨資料隱私問題、高昂的實施成本以及缺乏熟練的人工智慧和生物醫學專家的挑戰。儘管存在這些障礙，但開發用於早期疾病檢測和監測的人工智慧工具的機會仍然很多，需要創新方法和多學科合作。希望利用這些機會的公司可以透過與學術和研究機構合作來開發人工智慧解決方案來解決未滿足的臨床需求，從而受益。

創新應著重於整合人工智慧和穿戴式技術，開發用於患者特定預測的綜合人工智慧模型，並探索無監督學習技術以有效處理非結構化資料。該市場競爭激烈且發展迅速，成熟的醫療保健營業單位和高科技新興企業都進行了大量投資。公司必須持續監控監管變化和技術進步，才能在這個動態環境中保持領先地位。透過促進創新和策略合作，企業不僅可以克服當前的限制，還可以抓住新的成長機會。

市場動態：生物醫學市場快速發展的人工智慧的關鍵市場洞察

供需的動態交互作用正在改變生物醫學人工智慧市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球生物醫學領域數位化與研究的增加
    • 藥物發現和開發活動迅速增加
    • 對個人化和客製化醫療的需求不斷成長
  • 市場限制因素
    • 生物醫學領域人工智慧的高成本
  • 市場機會
    • 生物醫學解決方案中人工智慧的技術進步
    • 生物醫學解決方案人工智慧開發的有利投資環境
  • 市場挑戰
    • 資料隱私和安全問題

波特五力：駕馭生物醫學人工智慧市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解外部對生物醫學市場人工智慧的影響

外部宏觀環境因素對於塑造生物醫藥市場人工智慧的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物醫學人工智慧市場競爭格局

對生物醫學市場人工智慧的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 生物醫學市場人工智慧定位矩陣供應商績效評估

FPNV定位矩陣是評估生物醫學市場人工智慧供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製您在生物醫學市場人工智慧的成功之路

對於旨在加強其在全球市場的影響力的公司來說，生物醫學市場人工智慧的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球生物醫學領域的數位化和研究不斷增加
      • 藥物發現和開發活動迅速增加
      • 對個人化和客製化醫療保健的需求不斷成長
    • 抑制因素
      • 人工智慧在生物醫學領域的高成本
    • 機會
      • 生物醫學解決方案中人工智慧的技術進步
      • 生物醫學解決方案人工智慧開發的有利投資環境
    • 任務
      • 資料隱私和安全問題
  • 市場區隔分析
    • 類型：基於人工智慧的生物醫學軟體的大量採用
    • 應用：廣泛用於藥物發現與開發
    • 最終用戶：擴大以人工智慧為基礎的生物醫學解決方案在製藥公司的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物醫學領域的人工智慧市場：按組成部分

  • 硬體
  • 服務
  • 軟體

第7章生物醫學領域的人工智慧市場：依技術分類

  • 電腦視覺
  • 上下文感知計算
  • 機器學習
  • 自然語言處理
  • 查詢方式

第8章生物醫學領域的人工智慧市場：按應用分類

  • 臨床決策支持
  • 臨床試驗協調員和臨床實驗
  • 藥物發現與開發
  • 基因組學和個人化醫療
  • 醫學影像和放射診斷

第9章生物醫學領域的人工智慧市場：按最終用戶分類

  • 生技公司
  • 醫院和診斷中心
  • 製藥公司
  • 調查機構

第10章：美洲生物醫學領域的人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區生物醫學人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲生物醫學領域的人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Bionl.AI 推出無程式碼生物醫學研究創新平台
    • 認知 AI 在 BIO 上展示生物醫學 GPT
    • NIH 推出 Bridge2AI 計劃，擴大人工智慧和行為研究在生物醫學中的應用
  • 戰略分析和建議

公司名單

  • AiCure, LLC
  • Arterys Inc.
  • Aspen Technology Inc
  • Atomwise Inc
  • Augmedix, Inc.
  • Behold.ai Technologies Limited
  • BenevolentAI SA
  • BioSymetrics Inc.
  • BPGbio Inc.
  • Butterfly Network, Inc.
  • Caption Health, Inc. by GE Healthcare
  • Cloud Pharmaceuticals, Inc.
  • CloudMedX Inc.
  • Corti ApS
  • Cyclica Inc
  • Deargen Inc
  • Deep Genomics Incorporated
  • Euretos Services BV
  • Exscientia plc
  • Google, LLC by Alphabet, Inc.
  • Insilico Medicine
  • Intel Corporation
  • International Business Machines Corporation
  • InveniAI LLC
  • Isomorphic Labs
  • Novo Nordisk A/S
  • Sanofi SA
  • Turbine Ltd.
  • Viseven Europe OU
  • XtalPi Inc.
Product Code: MRR-A6768A62EDFF

The Artificial Intelligence in Biomedical Market was valued at USD 4.70 billion in 2023, expected to reach USD 5.78 billion in 2024, and is projected to grow at a CAGR of 24.18%, to USD 21.40 billion by 2030.

The scope of artificial intelligence (AI) in the biomedical sector encompasses a wide range of applications from drug discovery, genomics, and medical imaging to patient monitoring and personalized medicine. AI is integral due to its ability to analyze large datasets rapidly, identify complex patterns, and predict outcomes, thereby enhancing decision-making processes and operational efficiencies. In application, AI technologies like machine learning, natural language processing, and robotic process automation are being employed to optimize clinical trials, improve diagnostic accuracy, and accelerate the drug development process. End-use sectors include healthcare providers, pharmaceutical companies, and research institutions. Market growth is chiefly driven by the increasing demand for precision medicine, technological advancements in AI, and a growing volume of healthcare data. Further, government initiatives supporting AI and the Internet of Things (IoT) integration bolster the uptake of AI in biomedical applications.

KEY MARKET STATISTICS
Base Year [2023] USD 4.70 billion
Estimated Year [2024] USD 5.78 billion
Forecast Year [2030] USD 21.40 billion
CAGR (%) 24.18%

Key influencing growth factors include increasing healthcare expenditure, favorable regulatory environments, and collaborations between tech companies and healthcare providers. However, market expansion is challenged by concerns over data privacy, high implementation costs, and a shortage of skilled professionals in AI and biomedicine. Despite these hurdles, opportunities abound in the development of AI-powered tools for early disease detection and monitoring, which demand innovative approaches and interdisciplinary collaboration. For businesses aiming to capitalize on these opportunities, targeting AI solutions that address unmet clinical needs and collaborating with academic and research institutions may prove beneficial.

Innovation should focus on integrating AI with wearable technologies, developing comprehensive AI models for patient-specific predictions, and exploring unsupervised learning methods to handle unstructured data effectively. The nature of the market is competitive and rapidly evolving, with significant investment from both established healthcare entities and tech startups. Companies should continuously monitor regulatory changes and technological advancements to stay ahead in this dynamic environment. By fostering innovation and strategic collaboration, businesses can not only overcome present limitations but also tap into emerging opportunities for robust growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Biomedical Market

The Artificial Intelligence in Biomedical Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing digitalization and research in the biomedical sector worldwide
    • Surge in drug discovery & development activities
    • Rising demand for personalized and customized medicine
  • Market Restraints
    • High cost associated with AI in biomedical
  • Market Opportunities
    • Technological advancements in AI in biomedical solutions
    • Favorable investment landscape for the development of AI in biomedical solutions
  • Market Challenges
    • Concerns associated with data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Biomedical Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Biomedical Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Biomedical Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Biomedical Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Biomedical Market

A detailed market share analysis in the Artificial Intelligence in Biomedical Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Biomedical Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Biomedical Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Biomedical Market

A strategic analysis of the Artificial Intelligence in Biomedical Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Biomedical Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Arterys Inc., Aspen Technology Inc, Atomwise Inc, Augmedix, Inc., Behold.ai Technologies Limited, BenevolentAI SA, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Caption Health, Inc. by GE Healthcare, Cloud Pharmaceuticals, Inc., CloudMedX Inc., Corti ApS, Cyclica Inc, Deargen Inc, Deep Genomics Incorporated, Euretos Services BV, Exscientia plc, Google, LLC by Alphabet, Inc., Insilico Medicine, Intel Corporation, International Business Machines Corporation, InveniAI LLC, Isomorphic Labs, Novo Nordisk A/S, Sanofi SA, Turbine Ltd., Viseven Europe OU, and XtalPi Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Biomedical Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Components, market is studied across Hardware, Services, and Software.
  • Based on Technology, market is studied across Computer Vision, Context-Aware Computing, Machine Learning, Natural Language Processing, and Querying Method.
  • Based on Application, market is studied across Clinical Decision Support, Clinical Trial Coordinators & Investigators, Drug Discovery & Development, Genomics & Personalized Medicine, and Medical Imaging & Radiology.
  • Based on End-Users, market is studied across Biotechnology Firms, Hospitals & Diagnostic Centers, Pharmaceutical Companies, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing digitalization and research in the biomedical sector worldwide
      • 5.1.1.2. Surge in drug discovery & development activities
      • 5.1.1.3. Rising demand for personalized and customized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with AI in biomedical
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in AI in biomedical solutions
      • 5.1.3.2. Favorable investment landscape for the development of AI in biomedical solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significant penetration of AI-based biomedical software
    • 5.2.2. Application: Extensive use in drug discovery & development
    • 5.2.3. End-Users: Expanding applications of AI-based biomedical solutions in pharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Intelligence in Biomedical Market, by Components

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Artificial Intelligence in Biomedical Market, by Technology

  • 7.1. Introduction
  • 7.2. Computer Vision
  • 7.3. Context-Aware Computing
  • 7.4. Machine Learning
  • 7.5. Natural Language Processing
  • 7.6. Querying Method

8. Artificial Intelligence in Biomedical Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Decision Support
  • 8.3. Clinical Trial Coordinators & Investigators
  • 8.4. Drug Discovery & Development
  • 8.5. Genomics & Personalized Medicine
  • 8.6. Medical Imaging & Radiology

9. Artificial Intelligence in Biomedical Market, by End-Users

  • 9.1. Introduction
  • 9.2. Biotechnology Firms
  • 9.3. Hospitals & Diagnostic Centers
  • 9.4. Pharmaceutical Companies
  • 9.5. Research Institutions

10. Americas Artificial Intelligence in Biomedical Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Biomedical Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Biomedical Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bionl.AI Launches Innovative Platform for No-Code Biomedical Research
    • 13.3.2. Epistemic AI launches biomedical GPT at BIO
    • 13.3.3. NIH launches Bridge2AI program to expand the use of artificial intelligence in biomedical and behavioral research
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AiCure, LLC
  • 2. Arterys Inc.
  • 3. Aspen Technology Inc
  • 4. Atomwise Inc
  • 5. Augmedix, Inc.
  • 6. Behold.ai Technologies Limited
  • 7. BenevolentAI SA
  • 8. BioSymetrics Inc.
  • 9. BPGbio Inc.
  • 10. Butterfly Network, Inc.
  • 11. Caption Health, Inc. by GE Healthcare
  • 12. Cloud Pharmaceuticals, Inc.
  • 13. CloudMedX Inc.
  • 14. Corti ApS
  • 15. Cyclica Inc
  • 16. Deargen Inc
  • 17. Deep Genomics Incorporated
  • 18. Euretos Services BV
  • 19. Exscientia plc
  • 20. Google, LLC by Alphabet, Inc.
  • 21. Insilico Medicine
  • 22. Intel Corporation
  • 23. International Business Machines Corporation
  • 24. InveniAI LLC
  • 25. Isomorphic Labs
  • 26. Novo Nordisk A/S
  • 27. Sanofi SA
  • 28. Turbine Ltd.
  • 29. Viseven Europe OU
  • 30. XtalPi Inc.

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL TRIAL COORDINATORS & INVESTIGATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MEDICAL IMAGING & RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 196. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET, FPNV POSITIONING MATRIX, 2023